advertisement
Huang IW 21
Showing records 1 to 21 | Display all abstracts from Huang IW98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Cui X
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Wu WH
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Kim HJ
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Tsai YT; Huang IW
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Cheng CH
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Huang IW
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Jenny LA
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Cheng CH; Hsu CW
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
De Carvalho Junior JRL
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Cui X
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Chang YJ; Kong Y
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Ryu J; Quinn PMJ; Quinn PMJ
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Hsu CW
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Quinn PMJ; Caruso SM
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Huang IW
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Caruso SM
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Huang IW; Ragi SD
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Lin CS
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Lin CS
Human Molecular Genetics 2022; 31: 2438-2451
98807 CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa
Tsang SH
Molecular Therapy 2022; 30: 1407-1420
98900 Long-term vitamin a supplementation in a preclinical mouse model for RhoD190N-associated retinitis pigmentosa
Li X; Sparrow JR; Tsang SH
Human Molecular Genetics 2022; 31: 2438-2451
